Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.485 USD | +1.98% | +3.53% | -20.34% |
17/04 | Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating | MT |
15/04 | Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.34% | 765M | |
-18.43% | 27.14B | |
+21.30% | 10.8B | |
+1.03% | 4.85B | |
+2.51% | 511M | |
-11.16% | 452M | |
+0.19% | 301M | |
-23.60% | 215M | |
-39.65% | 186M | |
-4.23% | 156M |
- Stock Market
- Equities
- WKME Stock
- News WalkMe Ltd.
- Transcript : WalkMe Ltd., Q2 2023 Earnings Call, Aug 10, 2023